Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Accelerated H5N1 Vaccination with AS03 Adjuvant
NCT00695669Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2008
- Primary completion
- Aug 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated) in Avian influenza H5N1 (H5N1), sponsored by GSK. Started Jun 2008; status: completed.
02
Drugs
Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated)
03
Conditions
Avian influenza H5N1 (H5N1)
Beyond the preview
Go deeper on NCT00695669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00695669.